Jun 16, 2026 04:33PM
May 13, 2026 02:53PM
May 13, 2026 06:05AM
May 12, 2026 07:07AM
May 12, 2026 07:01AM
May 1, 2026 03:39PM
May 1, 2026 01:12PM Arvinas shares gain as FDA approves breast cancer drug Veppanu
Mar 20, 2026 06:47AM
Mar 18, 2026 03:48PM
Mar 18, 2026 11:18AM
Mar 6, 2026 06:46AM
Feb 24, 2026 02:24PM
Feb 24, 2026 07:08AM
Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026
Dec 8, 2025 02:55AM
Nov 24, 2025 07:02AM
Nov 10, 2025 06:33AM
Nov 5, 2025 07:18AM
Nov 3, 2025 04:00PM
Oct 30, 2025 06:05AM
Oct 24, 2025 04:00PM Arvinas presents preclinical data for cancer drug ARV-806
Oct 22, 2025 04:00PM
Oct 15, 2025 02:42AM
Oct 7, 2025 08:27AM
Oct 6, 2025 09:08AM
Sep 24, 2025 02:35AM
Sep 19, 2025 06:50AM
Sep 19, 2025 04:47AM Arvinas Inc. (ARVN) PT Lowered to $15 at Barclays
Sep 18, 2025 06:52AM
Sep 18, 2025 06:49AM
Sep 18, 2025 06:41AM
Sep 17, 2025 04:31PM
Sep 17, 2025 04:37AM
Aug 8, 2025 04:05PM
Aug 7, 2025 06:53AM Arvinas Inc. (ARVN) PT Lowered to $15 at Guggenheim
Aug 6, 2025 07:50AM
Jul 9, 2025 07:00AM
Jun 6, 2025 08:38AM
Jun 6, 2025 07:01AM
Jun 3, 2025 07:05AM
Jun 2, 2025 01:10AM
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 7, 2025 10:10AM
May 5, 2025 06:58AM
May 5, 2025 04:56AM
May 5, 2025 01:04AM
May 2, 2025 05:35AM
May 2, 2025 05:30AM
May 1, 2025 04:30PM Jefferies Downgrades Arvinas Inc. (ARVN) to Hold
May 1, 2025 04:05PM

416,806 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All